Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Champion

Showing results (1-10 of 114) with videos related to

Pageof 12
Sort By:
Life Sciences|January 1, 1997
[Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the ratH C Champion, P J Kadowitz
The American Journal of Physiology|August 1, 1997
NO release and the opening of K+ATP channels mediate vasodilator responses to histamine in the catH C Champion, P J Kadowitz
Hypertension (Dallas, Tex. : 1979)|November 22, 1997
Analysis of the effects of candesartan in the mesenteric vascular bed of the catH C Champion, P J Kadowitz
Journal of Cardiovascular Pharmacology|February 24, 1999
Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the ratH C Champion, P J Kadowitz
International Journal of Clinical Practice. Supplement|July 22, 2008
Right heart function and haemodynamics in pulmonary hypertensionA R Hemnes, H C Champion
Biochemical and Biophysical Research Communications|May 19, 1997
[Tyr1]-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the ratH C Champion, P J Kadowitz
The American Journal of Physiology|July 1, 1997
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanismH C Champion, P J Kadowitz
The Journal of Pharmacy and Pharmacology|July 29, 1998
Influence of nimodipine on vasoconstrictor responses in the hindquarters vascular bed of the catH C Champion, P J Kadowitz
European Journal of Pharmacology|May 7, 1998
R-(-)-alpha-methyl-histamine has nitric oxide-mediated vasodilator activity in the mesenteric vascular bed of the catH C Champion, P J Kadowitz
Life Sciences|January 1, 1997
Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the ratH C Champion, P J Kadowitz
Pageof 12

Showing results (1-10 of 114) with videos related to

Sort By:
Pageof 12
Life Sciences|January 1, 1997
[Tyr1]-nociceptin has naloxone-insensitive vasodilator activity in the hindquarters vascular bed of the ratH C Champion, P J Kadowitz
The American Journal of Physiology|August 1, 1997
NO release and the opening of K+ATP channels mediate vasodilator responses to histamine in the catH C Champion, P J Kadowitz
Hypertension (Dallas, Tex. : 1979)|November 22, 1997
Analysis of the effects of candesartan in the mesenteric vascular bed of the catH C Champion, P J Kadowitz
Journal of Cardiovascular Pharmacology|February 24, 1999
Vasodepressor responses to [D-Ala2]-endomorphin 2 (TAPP) are mediated by an L-NAME-sensitive mechanism in the ratH C Champion, P J Kadowitz
International Journal of Clinical Practice. Supplement|July 22, 2008
Right heart function and haemodynamics in pulmonary hypertensionA R Hemnes, H C Champion
Biochemical and Biophysical Research Communications|May 19, 1997
[Tyr1]-nociceptin, a novel nociceptin analog, decreases systemic arterial pressure by a naloxone-insensitive mechanism in the ratH C Champion, P J Kadowitz
The American Journal of Physiology|July 1, 1997
Vasodilator responses to acetylcholine, bradykinin, and substance P are mediated by a TEA-sensitive mechanismH C Champion, P J Kadowitz
The Journal of Pharmacy and Pharmacology|July 29, 1998
Influence of nimodipine on vasoconstrictor responses in the hindquarters vascular bed of the catH C Champion, P J Kadowitz
European Journal of Pharmacology|May 7, 1998
R-(-)-alpha-methyl-histamine has nitric oxide-mediated vasodilator activity in the mesenteric vascular bed of the catH C Champion, P J Kadowitz
Life Sciences|January 1, 1997
Nociceptin, an endogenous ligand for the ORL1 receptor, has novel hypotensive activity in the ratH C Champion, P J Kadowitz
Pageof 12